ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients

ClinicalTrials.gov ID: NCT00931918

Public ClinicalTrials.gov record NCT00931918. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 3:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Randomized, Phase 2 Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients

Study identification

NCT ID
NCT00931918
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Millennium Pharmaceuticals, Inc.
Industry
Enrollment
206 participants

Conditions and interventions

Interventions

  • Bortezomib Drug
  • Cyclophosphamide Drug
  • Doxorubicin Drug
  • Prednisone Drug
  • Rituximab Drug
  • Vincristine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2009
Primary completion
Jul 31, 2015
Completion
Jul 31, 2015
Last update posted
Jan 10, 2017

2009 – 2015

United States locations

U.S. sites
70
U.S. states
24
U.S. cities
61
Facility City State ZIP Site status
Tower Cancer Research Foundation Beverly Hills California 90211
Fountain Valley Regional Hospital Fountain Valley California 92708
St. Jude Heritage Healthcare Fullerton California 92835
Moores Cancer Center- UCSD La Jolla California 92093
Antelope Valley Cancer Center Lancaster California 93534
Loma Linda University Cancer Center Loma Linda California 92354
University of Southern California Los Angeles California 90033
Jonsson Comprehensive Cancer Center Los Angeles California 90095
TORI- Central Pharmacy Los Angeles California
TORI- Central Regulatory Los Angeles California
Oncology Care Medical Associates Montebello California 90640
Bay Area Cancer Research Group Pleasant Hill California 94523
Wilshire Oncology Medical Group Rancho Cucamonga California 91730
Sharp Healthcare San Diego California 32123
Central Coast Medical Oncology Corporation Santa Maria California 93454
Rocky Mountain Cancer Center Denver Colorado 80218
Florida Cancer Specialists Fort Myers Florida 33619
Florida Cancer Specialists & Research Institute Gainsville Florida 32605
Alves/ Domenech Oncology-Hematology Clinic Hollywood Florida 33019
Florida Cancer Institute ATI New Port Richey Florida 34655
MD Anderson Cancer Center of Orlando Orlando Florida 32806
Coastal Oncology, PL Ormond Beach Florida 32174
Winship Cancer Institute at Emory University Atlanta Georgia 30322
Georgia Cancer Specialists Atlanta Georgia 30341
Dublin Hematology and Oncology Dublin Georgia 31021
Rush University Medical Center Chicago Illinois 60612
Central Indiana Cancer Centers Fishers Indiana 46227
Cancer Care Center Inc. P.C. New Albany Indiana 47150
Iowa Blood and Cancer Care Cedar Rapids Iowa 52401
Iowa Oncology Research Association Des Moines Iowa 50309
Siouxland Hematology and Oncology Associates LLP Sioux City Iowa 51101
Kansas City Cancer Center, LLC Overland Park Kansas 66210
Sinai Hospital of Baltimore Baltimore Maryland 21215
St. Agnes Hospital of Baltimore Baltimore Maryland 21229
Holy Cross Hospital Silver Spring Maryland 20910
Lahey Clinic Medical Center Burlington Massachusetts 01805
Berkshie Hematology Oncology Pittsfield Massachusetts 01201
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201
Mid Michigan Physicians Lansing Michigan 48912
Duluth Clinic Duluth Minnesota 55805
St. Luke's Hospital Cancer Care Center Duluth Minnesota 55805
Missouri Cancer Associates Columbia Missouri 65201
Saint Luke's Cancer Institute Kansas City Missouri 64111
Hackensack University Medical Center Hackensack New Jersey 07601
Hematology/Oncology Associates of Northern New Jersey, P.A. Morristown New Jersey 07962
Hematology Oncology Associates of South Jersey Mount Holly New Jersey 08060
St. Luke's- Roosevelt Medical Center New York New York 10019
Cornell New York New York
Raleigh Hematology Oncology Associates P.C. Raleigh North Carolina 27607
Summa Health System Akron Ohio 44304
Oncology Hematology Care Cincinnati Ohio 45267
Kaiser Group Health Portland Oregon 97227
Hematology and Oncology Associates of NEPA Dunmore Pennsylvania 18512
UPMC Cancer Center Pittsburgh Pennsylvania 15232
Guthrie Clinic Sayre Pennsylvania 18840
Berks Hematology Oncology Associates West Reading Pennsylvania 19611
South Carolina Oncology Associates, PA Columbia South Carolina 29201
Chattanooga Oncology and Hematology Associates, PC Chattanooga Tennessee 37404
Tennessee Oncology Nashville Tennessee 37203
Texas Oncology Cancer Center Austin Texas 78731
US Oncology- Central Drug Fort Worth Texas 76177
US Oncology- Central Laboratory Fort Worth Texas 76177
Oncology Consultants P.A. Houston Texas 77024
Oncology Consultants Houston Texas 77030
US Oncology- Central Regulatory The Woodlands Texas 77380
Tyler Cancer Center Tyler Texas 75702
Texoma Cancer Center Wichita Falls Texas 76310
Virginia Cancer Institute Richmond Virginia 23230
Puget Sound Cancer Centers Edmonds Washington 98026
Northwest Cancer Specialists PC Vancover Washington 98686

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00931918, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 10, 2017 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00931918 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →